Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-07-21

Clinical Trial Update: The Randomized Controlled Clinical Trial of Kushen Injection [Phase 4]

View source ↗

Summary

Update on a Phase 4 randomized controlled trial evaluating Kushen Injection for lung cancer; current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Kushen Injection

Snippet

Sponsor: Beijing Zheng Ju Medical Technology Co., Ltd. | Conditions: Lung Cancer | Phase 4 | Status: UNKNOWN